Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
Want to see AU:ARX full AI Analyst Report?
Total Valuation
Aroa Biosurgery Ltd has a market cap or net worth of AU$223.11M. The enterprise value is AU$227.87M.
Market CapAU$223.11M
Enterprise ValueAU$227.87M
Share Statistics
Aroa Biosurgery Ltd has 345,902,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding345,902,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aroa Biosurgery Ltd’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.94%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.94%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee338.04K
Profits Per Employee15.23K
Employee Count273
Asset Turnover0.92
Inventory Turnover2.52
Valuation Ratios
The current PE Ratio of Aroa Biosurgery Ltd is 64.8. Aroa Biosurgery Ltd’s PEG ratio is -0.22.
PE Ratio64.8
PS Ratio2.23
PB Ratio2.48
Price to Fair Value2.48
Price to FCF24.50
Price to Operating Cash Flow20.23
PEG Ratio-0.22
Income Statement
In the last 12 months, Aroa Biosurgery Ltd had revenue of 92.28M and earned 4.16M in profits. Earnings per share was 0.01.
Revenue92.28M
Gross Profit79.63M
Operating Income4.36M
Pretax Income3.85M
Net Income4.16M
EBITDA9.03M
Earnings Per Share (EPS)0.01
Cash Flow
In the last 12 months, operating cash flow was 9.09M and capital expenditures -955.41K, giving a free cash flow of 8.13M billion.
Operating Cash Flow9.09M
Free Cash Flow8.13M
Free Cash Flow per Share0.02
Dividends & Yields
Aroa Biosurgery Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change19.44%
50-Day Moving Average0.59
200-Day Moving Average0.66
Relative Strength Index (RSI)51.99
Average Volume (3m)302.12K
Important Dates
Aroa Biosurgery Ltd upcoming earnings date is May 25, 2026, After Close (Confirmed).
Last Earnings DateNov 25, 2025
Next Earnings DateMay 25, 2026
Ex-Dividend Date―
Financial Position
Aroa Biosurgery Ltd as a current ratio of 4.77, with Debt / Equity ratio of 6.42%
Current Ratio4.77
Quick Ratio4.40
Debt to Market Cap<0.01
Net Debt to EBITDA-1.35
Interest Coverage Ratio10.37
Taxes
In the past 12 months, Aroa Biosurgery Ltd has paid -310.12K in taxes.
Income Tax-310.12K
Effective Tax Rate-0.08
Enterprise Valuation
Aroa Biosurgery Ltd EV to EBITDA ratio is 21.39, with an EV/FCF ratio of 23.04.
EV to Sales2.09
EV to EBITDA21.39
EV to Free Cash Flow23.04
EV to Operating Cash Flow20.62
Balance Sheet
Aroa Biosurgery Ltd has AU$22.60M in cash and marketable securities with AU$5.31M in debt, giving a net cash position of AU$17.29M billion.
Cash & Marketable SecuritiesAU$22.60M
Total DebtAU$5.31M
Net CashAU$17.29M
Net Cash Per ShareAU$0.05
Tangible Book Value Per ShareAU$0.19
Margins
Gross margin is 85.83%, with operating margin of 4.72%, and net profit margin of 4.50%.
Gross Margin85.83%
Operating Margin4.72%
Pretax Margin4.17%
Net Profit Margin4.50%
EBITDA Margin9.79%
EBIT Margin4.72%
Analyst Forecast
The average price target for Aroa Biosurgery Ltd is AU$1.08, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$1.08
Price Target Upside103.14% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast19.23%
EPS Growth Forecast―